Lausanne, Switzerland · Founded 2023 · Privately Held (backing)
Developer of next-generation CAR-T cell therapies designed to cure solid tumours, specifically targeting aggressive brain cancers. Cellula Therapeutics is based in Lausanne, Switzerland and was founded in 2023. Its last reported valuation was $13.9 million in Jul 2025. It has raised $3.6 million.
Last reported valuation
$13.9M
Oct 2026
Priced at
—
Total raised
$3.6M
Last round
—
Team — not yet on record
No current team members for Cellula Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Cellula Therapeutics with a free Private Market View account
·Watch Cellula Therapeutics: the Monday email on marks, rounds and moves
